Mona Sadat Larijani

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Infection with the hepatitis C virus is a major public health concern which can lead to carcinoma and liver failure. It has been shown that single nucleotide polymorphisms can affect the level of gene activity of tumor necrosis factor (TNF) which has an important role, especially in viral infections which can lead to apaptosis of infected hepatocellular(More)
BACKGROUND Hepatitis C virus as a major cause of chronic liver disease affects more than 170 million people worldwide. Recent studies have claimed that single nucleotide polymorphisms (SNPs) for the transforming growth factor-β1 (TGF-β1) gene were strongly associated with the antiviral treatment response. Thus, the present study aimed at the determination(More)
The worldwide prevalence of hepatitis C virus (HCV) infection is approximately 3%. Hopelessly, Only 15% of those who contract HCV are able to spontaneously clear the virus. Thus 85% of infected people are at the risk for developing cirrhosis and hepatocellular carcinoma in further years after infection. Furthermore, HCV infection is the most common reason(More)
BACKGROUND The current standard treatment for hepatitis C is a combination of pegylated interferon alpha and ribavirin (peg-IFNα/RBV). Recent studies have shown that single nucleotide polymorphisms (SNPs) near the interleukin 28B (IL28B) gene coding for IFN-λ3 were associated with the antiviral treatment response. Therefore, in this study, we determined the(More)
METHODS This case-control study, was performed on 136 blood samples based on 81 patients with chronic HCV genotypes 1 and 3 including 64 SVR positive and 17 negative and 55 healthy individual controls. DNA was isolated from the samples and the frequency of the polymorphism was analyzed using a PCR-RFLP method. Finally, the products were detected on 3.5%(More)
  • 1